B. Riley’s Top Biotech Pick: 4D Molecular Therapeutics
B. Riley Names 4D Molecular Therapeutics a Top Biotech Pick B. Riley Securities has reaffirmed 4D Molecular Therapeutics (NASDAQ: FDMT) a...
Category: Gene Therapy
Lexeo Stock Rises on $21.3M Mantle FA Deal
Lexeo Stock Rises on $21.3M Mantle Deal for Friedreich Ataxia Therapies Lexeo Therapeutics stock moved higher on September 22 after the cl...